logo-loader
RNS
Tate & Lyle PLC

Tate & Lyle PLC - Court approval of cancellation of Pref. shares

RNS Number : 3166Z
Tate & Lyle PLC
13 September 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

 

13 September 2022

 

Tate & Lyle PLC

("Tate & Lyle" or the "Company")


Cancellation and repayment of 6½ per cent. cumulative preference shares approved by Court

 

Further to the announcements made on 15 June 2022 and 28 July 2022, Tate & Lyle is pleased to announce that the High Court has today approved the proposed reduction of the Company's share capital through the cancellation and repayment of its 6½ per cent. cumulative preference shares (the "Preference Shares" and the "Reduction", respectively).

The Reduction will become effective upon the order of the High Court being registered by the Registrar of Companies, which is expected to take place between 21 September 2022 and 30 September 2022. Tate & Lyle will also be making applications to the Financial Conduct Authority and the London Stock Exchange for:

·      the suspension of the listing of the Preference Shares on the Standard Segment of the Official List maintained by the Financial Conduct Authority and to trading on the Main Market of the London Stock Exchange with effect from 7.30 a.m. on 20 September 2022; and

·      the subsequent cancellation of the listing of the Preference Shares on the Standard Segment of the Official List maintained by the Financial Conduct Authority and to trading on the Main Market of the London Stock Exchange shortly after the Reduction has become effective.

Assuming that the Reduction becomes effective, repayments of amounts due to holders of Preference Shares would then be made.

Expected Timetable

Event

Expected time and/or date(1)

Last day of dealings in, and for registration of transfers of, and disablement in CREST of, the Preference Shares

16 September 2022

Repayment record time and date

6.00 p.m. on 16 September 2022

Suspension of trading of Preference Shares 

7.30 a.m. on 20 September 2022

Effective date for the Reduction

Between 21 September 2022
and 30 September 2022(2)

Cancellation of listing and trading of Preference Shares

Between 21 September 2022
and 30 September 2022(3)

Despatch of cheques and crediting of CREST accounts in respect of the repayment of the Preference Shares and dividends accrued thereon

 

On or around 30 September 2022

(1)   The dates and times given are indicative only and are based on current expectations and may be subject to change. References to times are London time, unless otherwise stated. If any of the times and/or dates above change, the revised times and/or dates will be announced via a Regulatory Information Service.

(2)   In order for the Reduction to become effective, the High Court order confirming the Reduction must be registered at the Registrar of Companies, which can take a number of days.

(3)   It is expected that the cancellation of listing and trading of the Preference Shares will take place shortly after the Reduction has become effective.

 

For more information contact:

 

Investors and analysts

Christopher Marsh, VP Investor Relations

Tel - Mobile: +44 (0) 7796 192 688

 

 

Information on Tate & Lyle

 

Tate & Lyle is a leading global provider of food and beverage ingredients and solutions. Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, mouthfeel and fibre fortification, we develop solutions which reduce sugar, calories and fat, add fibre, and provide texture and stability in categories including beverages, dairy, bakery, soups, sauces and dressings.

We have more than 3,500 employees working in around 60 locations across 30 countries. Tate & Lyle's purpose is Transforming Lives Through the Science of Food and through our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year ended 31 March 2022, Tate & Lyle's revenue from continuing operations totaled £1.4 billion. For more information, please visit http://www.tateandlyle.com or follow Tate & Lyle on Twitter or LinkedIn.

Tate & Lyle's LEI number is: 2138008K14474WPKZ244

Important notes

 

This announcement is not intended to, and does not constitute or form part of, and should not be construed as, any offer, invitation, solicitation or recommendation of an offer to purchase, sell, subscribe for or otherwise dispose of or acquire any securities or the solicitation of any vote or approval in any jurisdiction and neither the issue of the information nor anything contained herein shall form the basis of or be relied upon in connection with, or act as an inducement to enter into, any investment activity. No shares are being offered to the public by means of this announcement. This announcement does not constitute either advice or a recommendation regarding any securities, or purport to contain all of the information that may be required to evaluate any investment in Tate & Lyle or any of its securities and should not be relied upon to form the basis of, or be relied on in connection with, any contract or commitment or investment decision whatsoever. Past performance is not an indication of future results and past performance should not be taken as a representation that trends or activities underlying past performance will continue in the future.

Shareholders are advised to carefully read the Notice, once available. Any response to the Reduction should be made only on the basis of the information in the Notice. If you are in any doubt as to what action you should take in relation to this announcement or in connection with the Reduction, you are recommended to seek your own personal financial advice immediately from your stockbroker, bank manager, solicitor, accountant or other independent financial adviser authorised under the Financial Services and Markets Act 2000, or from another appropriately authorised independent financial adviser.

The distribution of this announcement in jurisdictions or from certain jurisdictions may be restricted or prohibited by the laws of any jurisdiction other than the United Kingdom. Recipients are required to inform themselves of, and comply with, all restrictions or prohibitions in such other jurisdictions. Any failure to comply with applicable requirements may constitute a violation of the laws and/or regulations of other such jurisdiction.

This announcement has been prepared for the purposes of complying with the applicable law and regulation of the United Kingdom (including the Listing Rules and the Disclosure Guidance and Transparency Rules) and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of the United Kingdom.

This announcement is being distributed to all shareholders in Tate & Lyle. A copy of this announcement can be found on our website at www.tateandlyle.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUOVORUAUKAAR
NO INVESTMENT ADVICE

Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.

Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.

In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.

The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.

Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

FOR OUR FULL DISCLAIMER CLICK HERE

Form 8.3 - Tate & Lyle plc

6 hours, 43 minutes ago

Form 8.3 - Tate & Lyle

7 hours, 27 minutes ago

Form 8.3 - Tate & Lyle plc

8 hours, 7 minutes ago

Form 8.3 - Tate & Lyle plc

9 hours, 18 minutes ago

Form 8.3 - Tate & Lyle plc

9 hours, 24 minutes ago

Form 8.3 Tate & Lyle Plc

9 hours, 33 minutes ago

Form 8.3 - Tate & Lyle plc

9 hours, 45 minutes ago

7 min read